ArticleAntimicrobial agents and chemotherapy2026
Isobavachalcone effectively inhibits the growth of
Ping Xie, Wenting Zhou, Jiazi Luo, Yuanyuan Dai, Shixian Yang, Shufang Li, Yanqiang Huang
Abstract read
In one paragraphArticle in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Ping Xie *Guangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise, China.
Wenting Zhou *Guangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise, China.
Jiazi LuoGuangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise, China.
Yuanyuan DaiDepartment of Stomatology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Shixian YangDepartment of Stomatology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.ORCID 0009-0001-4377-4562 Shufang LiDepartment of Stomatology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.ORCID 0000-0003-4679-4005 Yanqiang HuangGuangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise, China.ORCID 0000-0002-0867-0178 Funding
Guangxi Science and Technology Major projects AA23073012National Natural Science Foundation of China 32060018National Natural Science Foundation of China 32360035
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Antifungal AgentsCandida albicansChalconesAdenosine TriphosphateAnimalsCandidiasisCandidiasis, OralCandidiasis, VulvovaginalFemaleFluconazoleFungal ProteinsMiceMicrobial Sensitivity TestsOxidative StressAdenosine TriphosphateAntifungal AgentsChalconesFluconazoleFungal ProteinsisobavachalconeADK1antifungal mechanismATP biosynthesisC. albicansisobavachalcone
Identifiers
PMID41416799
PMCPMC12888897
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390